Home

Explore NIH Technologies

Explore work by over 1,500 NIH researchers   |   Available for Licensing & Collaboration

 
Register to attend a free NIH webinar to learn about a new non-opioid small molecule for treating opioid use and substance use disorders by selectively targeting the dopamine D3 receptor. Dr. Amy Newman and her team at the National Institutes of Health’s National Institute on Drug Abuse (NIDA)
1 in every 200 people in the US with eye-related irritation are suffering from uveitis. Prolonged use of drugs that help treat chronic uveitis can cause serious side effects such as glaucoma. Having an alternative treatment for uveitis available is imperative. NIH inventors have proposed targeting
If you are an experienced Technology Transfer & Patent Specialist and you want to play a significant role in a dynamic organization, then consider joining the National Institutes of Health! This position is open 4/20-4/24/2026. Duties: Originate and draft complex Cooperative Research and Development

Explore Featured Research

Get updates on the latest and most exciting research coming out of NIH...

Read More >

Explore Featured Products

Novel and interesting products coming to market through NIH inventions and partnerships...

Read More >